In vitro experiments demonstrated that the resistance of melanoma cells was reduced by clearing senescent cells: EGFR–SRC–STAT3 pathway activation was upregulated in BRAFi‐resistant melanoma cells. The gene discussed is SRC; the disease is melanoma.